Fundraising FoxCOG BioPharma Services
Indianapolis, US · Founded 2020 · Delaware corporation
Find your way into COG BioPharma Services
Sign up to see every warm intro you have to COG BioPharma Services
- Paths you didn't know you had: your email and LinkedIn already hold routes to the COG BioPharma Services team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TG
Tedd GreenNamed on SEC filing
FB
Fabrizio BonanniNamed on SEC filing
CL
Cory LewisNamed on SEC filing
MV
Martin Van TriesteNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$86.6M disclosed across 3 rounds · 2020–2024
▶$42.9MraisedMay 2024 · 1 investors · Other Health CareRule 506(b)
▶$42.9MraisedMay 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tedd GreenExecutive Officer
- Doug DayoffExecutive Officer
- Madhu BalachandranDirector
- Cory LewisExecutive Officer, Director
- Fabrizio BonanniDirector
- Karen BlairDirector
- Keith SkerrettDirector
- Offering amount
- $42.9M
- Amount sold
- $42.9M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$15MraisedMay 2022 · 5 investors · Other Health CareRule 506(b)
▶$15MraisedMay 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Doug DayoffExecutive Officer
- Tedd GreenExecutive Officer
- Cory LewisExecutive Officer, Director
- Fabrizio BonanniDirector
- Martin Van TriesteDirector
- Offering amount
- $25M
- Amount sold
- $15M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$28.8MraisedSep 2020 · 3 investors · Other Health CareRule 506(b)
▶$28.8MraisedSep 2020 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tedd GreenExecutive Officer
- Fabrizio BonanniDirector
- Cory LewisExecutive Officer, Director
- Martin Van TriesteDirector
- Offering amount
- $51M
- Amount sold
- $28.8M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has COG BioPharma Services raised?
- COG BioPharma Services has disclosed $86.6M raised across 3 rounds.
- Where is COG BioPharma Services headquartered?
- COG BioPharma Services is headquartered in Indianapolis, US.